Apr 17, 2020
Visiongain Report: The Gene Therapy Market is Projected to Grow at a CAGR of 32% in the First Half of the Forecast Period
Dec 06, 2019
Global Gene Therapy Market Growth, Company Profiles, Clinical trials and Forecasts to 2022 - ReportsnReports
Jul 05, 2019
ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia
Jun 12, 2019
Invitae Announces ID YOUR IRD Program to Expand Access to Genetic Testing for Inherited Retinal Disorders
May 30, 2019
The Greater Philadelphia Region's Place at the Forefront of Cell and Gene Therapy and Connected Health Research and Treatment To Be Showcased During BIO 2019 in Philadelphia
Dec 05, 2018
Children's Hospital Celebrates European Commission Approval of First-of-Its-Kind Gene Therapy for Blindness
Nov 09, 2018
Gene Therapy Markets: Global and US Analysis (2018-2020) - Rising Focus to Accelerate Commercialization of Gene Therapy in Developed Nations
Sep 25, 2018
Global Gene Therapy Market 2018-2022: Market to Grow at a CAGR of 22.42% with Biogen, Gilead, Novartis, Orchard Therapeutics & Spark Therapeutics Dominating
Jun 12, 2018
Gene Therapy R&D and Revenue Forecasts 2018-2028 - Visiongain Report
May 21, 2018
coreHEM Publishes Core Outcome Set for Hemophilia Clinical Trials; Prepares to Launch Next Phase of Work
Mar 07, 2018
Global Gene Therapy Market 2018-2022: $363 Mn Driven by 2,200+ Clinical Trials with Over 55% of this Occurring in the US, Followed by Europe, Canada and China
Dec 19, 2017
Children's Hospital of Philadelphia Celebrates FDA Approval of Gene Therapy for Inherited Blindness
Dec 19, 2017
Foundation Fighting Blindness Celebrates Historic FDA Approval of First Gene Therapy to Treat Blindness